LUNG VASCULAR & CELLULAR ACTIONS OF C3A, C5A, & FMLP
肺血管
基本信息
- 批准号:3087486
- 负责人:
- 金额:$ 8.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-09-01 至 1992-08-31
- 项目状态:已结题
- 来源:
- 关键词:NAD(H) phosphate adult respiratory distress syndrome alveolar macrophages aminopyridines anaphylatoxins antibody receptor antihistamines arachidonate arginine benzofurans cardiovascular pharmacology cimetidine complement pathway complement receptor dimethylsulfoxide eicosanoid metabolism enzyme inhibitors flow cytometry fluorescent dye /probe histamine release histology hydrogen peroxide ibuprofen immunoglobulin G laboratory rabbit methylprednisolone oligopeptides peptide analog phagocytosis phorbols prostaglandin endoperoxide synthase prostaglandins pulmonary artery pulmonary circulation thromboxanes vascular endothelium permeability vasoactive agent vasoconstriction
项目摘要
The adult respiratory distress syndrome (ARDS) is characterized
by pulmonary vasoconstriction as well as accumulation of cells
and protein-rich fluid within the lung parenchyma. The
mechanisms of these abnormalities are not understood. C3a and
C5a, the anaphylatoxin products of complement activation, and
formaylated oligopeptide bacterial products (e.g. formyl
methionine-leucine-phenylalanine; fMLP) may be important in the
development of these abnormalities. In this proposal we will
investigate the actions of C3a, C5a, and fMLP on isolated
pulmonary artery segments and pulmonary macrophages from
rabbits. The specific aims of this project are: 1. To determine if
C3a, C5a, their des arg derivatives, or fMLP constrict isolated
rabbit pulmonary artery ring segments. We will construct dose-
response curves, and evaluate tissue desensitization, synergism,
and cross-reactivity between these peptides. 2. To determine
through the use of pharmacologic inhibitors if the actions of these
peptides are attributable to the release of histamine or
arachidonic acid metabolities. 3. To determine the role of
endothelium in the actions of these peptides on isolated
pulmonary artery segments by testing their effects on segments
which have undergone mechanical denuding of endothelium. 4. To
identify receptors for these peptides in pulmonary tissues utilizing
fluorescent probes for C3a, C5a, and fMLP. 5. To analyze
physical parameters, ligand binding characteristics, and functional
properties of pulmonary macrophages through the use of
multiparameter flow cytometry. These studies will broaden our
understanding of cellular and vascular responses to C3a, C5a, and
fMLP, and may result in the development of more effective
therapeutic modalities for ARDS.
成人呼吸窘迫综合征(ARDS)的特征
通过肺血管收缩和细胞积聚
和肺实质内富含蛋白质的液体。这个
这些异常的机制尚不清楚。C3a和
补体激活的过敏性毒素产物C5a,以及
甲酰化寡肽细菌产品(例如甲酰
蛋氨酸-亮氨酸-苯丙氨酸;fMLP)可能在
这些异常的发展。在本提案中,我们将
研究补体C3a、C5a和fMLP在体外培养中的作用
肺动脉节段和肺巨噬细胞
兔子。这个项目的具体目标是:1.确定是否
C3a、C5a、它们的Des Arg衍生物或fMLP收缩隔离
兔肺动脉环节段。我们将构建剂量-
反应曲线,并评估组织脱敏,协同作用,
以及这些多肽之间的交叉反应。2.确定
通过使用药物抑制剂,如果这些药物的作用
多肽可归因于组胺或
花生四烯酸代谢。3.确定
血管内皮细胞在这些多肽对血管内皮细胞的作用
通过测试其对节段的影响来确定肺动脉节段
它们已经接受了内皮的机械剥离。4.至
在肺组织中识别这些多肽的受体
C3a、C5a和fMLP的荧光探针。5.分析
物理参数、配体结合特性和官能团
肺巨噬细胞的特性
多参数流式细胞术。这些研究将拓宽我们的
了解细胞和血管对C3a、C5a和
FMLP,并可能导致开发出更有效的
ARDS的治疗方式。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nonsteroidal antiinflammatory agents inhibit upregulation of CD11b, CD11c, and CD35 in neutrophils stimulated by formyl-methionine-leucine-phenylalanine.
非甾体类抗炎药可抑制甲酰甲硫氨酸-亮氨酸-苯丙氨酸刺激的中性粒细胞中 CD11b、CD11c 和 CD35 的上调。
- DOI:10.1007/bf00917455
- 发表时间:1990
- 期刊:
- 影响因子:5.1
- 作者:Crowell,RE;VanEpps,DE
- 通讯作者:VanEpps,DE
Pentoxifylline relaxes isolated pulmonary arteries after preconstriction with norepinephrine.
去甲肾上腺素预收缩后,己酮可可碱可松弛孤立的肺动脉。
- DOI:10.1159/000195818
- 发表时间:1990
- 期刊:
- 影响因子:0
- 作者:Crowell,RE;Chick,TW;Reed,WP
- 通讯作者:Reed,WP
Responses of isolated pulmonary arteries to the C5a anaphylatoxin.
离体肺动脉对 C5a 过敏毒素的反应。
- DOI:10.1152/ajpheart.1990.259.5.h1325
- 发表时间:1990
- 期刊:
- 影响因子:0
- 作者:Crowell,RE;VanEpps,DE;Reed,WP
- 通讯作者:Reed,WP
Responses of isolated pulmonary arteries to synthetic peptide F-Met-Leu-Phe.
离体肺动脉对合成肽 F-Met-Leu-Phe 的反应。
- DOI:10.1152/ajpheart.1989.257.1.h107
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:Crowell,RE;VanEpps,DE;Reed,WP
- 通讯作者:Reed,WP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD E CROWELL其他文献
RICHARD E CROWELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD E CROWELL', 18)}}的其他基金
相似海外基金
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6564818 - 财政年份:2001
- 资助金额:
$ 8.75万 - 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
- 批准号:
6410976 - 财政年份:2000
- 资助金额:
$ 8.75万 - 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6418789 - 财政年份:2000
- 资助金额:
$ 8.75万 - 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6302122 - 财政年份:1999
- 资助金额:
$ 8.75万 - 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
- 批准号:
6309780 - 财政年份:1999
- 资助金额:
$ 8.75万 - 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6109540 - 财政年份:1998
- 资助金额:
$ 8.75万 - 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
- 批准号:
6265845 - 财政年份:1998
- 资助金额:
$ 8.75万 - 项目类别:














{{item.name}}会员




